Nanotoxikologie

Auger F, Gendron MC, Chamot C, Marano F, Dazy AC (2006) Responses of well-differentia-ted nasal epithelial cells exposed to particles: role of the epithelium in airway inflammation. Toxicol Appl Pharmacol 215:285–294

BCC (Hrsg. 2006) Nanotechnology: A realistic market assessment. unter www.bccresearch.com/nanotechnology

Böcher A, Müller M, Buchter A (2005) Nano-partikel in der Arbeitsmedizin–gesundheitliche Risiken und Präventionsbedarf. Saarländisches Ärzteblatt 8:17–24

Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdörster E (2006) The potential risks of nanomaterials: a review carried out for ECE-TOC. Part Fibre Toxicol 3:1–35

Brown JS, Zeman KL, Bennett WD(2002) Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240–1247

Bundesanstalt für Arbeitsschutz und Arbeits-medizin, Bundesinstitut für Risikobewertung, Umweltbundesamt (Hrsg. 2006) Nanotechno-logie: Gesundheits- und Umweltrisiken von Nanomaterialien. unter www.baua.de

Bundesamt für Umwelt (BAFU), Bundesamt für Gesundheit (BAG) der Schweiz (Hrsg. 2007) Synthetische Nanomaterialien: Risiko-beurteilung und Risikomanagement. unter www.umwelt-schweiz.ch

Bundesinstitut für Risikobewertung (Hrsg. 2006) Nanopartikel waren nicht die Ursache für Ge-sundheitsprobleme durch Versiegelungssprays! Produkte enthielten keine ultrafeinen Partikel.unter www.bfr.bund.de/cd/7839

Bundesinstitut für Risikobewertung (Hrsg. 2007) Ultrafeinstäube aus Laserdruckern und Foto-kopierern enthalten offenbar keine Tonerparti-kel. unter http://www.bfr.bund.de/cd/10150

Campbell A, Oldham M, Becaria A, Bondy SC, Meacher D, Sioutas C, Misra C, Mendez LB, Kleinman M (2005) Particulate matter in pollu-ted air may increase biomarkers of inflammati-on in mouse brain. Neurotoxicology 26:133–140

Campen J, McDonald JD, Gigliotti AP, Seilkop SK, Reed MD, Benson JM (2003) Cardiovascu-lar effects of inhaled diesel exhaust in spon-taneously hypertensive rats. Cardiovasc Toxicol 3:353–361

Diaz-Sanchez D, Dotson AR, Takenaka H, Saxon A (1994) Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest 94:1417–1425

Diaz-Sanchez D, Jyrala M, Ng D, Nel A, Saxon A (2000) In vivo nasal challenge with diesel ex-haust particles enhances expression of the CC chemokines rantes, MIP1-alpha, and MCP-3 in humans. Clin Immunol 97:140–145

Donaldson K, Tran L, Jimenez L, Duffin R, Newby DE, Mills N, MacNee W, Stone V (2005) Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Part Fibre Toxicol 2: 10

Elder ACP, Gelein R, Finkelstein JN, Cox C, Oberdörster G (2000) Pulmonary inflammatory response to inhaled ultrafine particles is modi-fied by age, ozone exposure, and bacteria toxin. Inhal Toxicol 12:227–246

Ferin J, Oberdörster G, Soderholm SC, Gelein R (1991) Pulmonary tissue access of ultrafine Particles. J Aerosol Med 4:57–68

Frampton MW, Utell MJ, Zarebra W, Oberdörster G, Cox C, Huang LS, Morrow PE, Lee FE, Chalupa D, Frasier LM, Speers DM, Stewart J (2004) Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst 126:1–4

Geiser M, Rothen-Rutishauser B, Knapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P (2005) Ultrafine particles cross cellular membranes by nonphago-cytic mechanisms in lungs and in cultured cells. Environ Health Persp 113:1555–1560

Groß J (2003): Luftverschmutzung durch Parti-kel. Umwelt-Medizin-Gesellschaft 16:241–244

Homma S, Miyamato A, Sakamoto S, Kishi K, Motoi N, Yoshimura K (2005) Pulmonary fibro-sis in an individual occupationally exposed to inhaled indium-tin-oxide. Eur Resp J 25:200–204

Hunt A, Abraham JL, Judson B, Berry CL (2003) Toxicologic and epidemiologic clues from the characterization of the 1952 London smog fine particulate matter in archival auto-psy lung tissues. Environ Health Perspect 111:1209–1214

Jani PU, McCarthy DE, Florence AT (1994) Titanium dioxide (rutile) particles uptake from the rat GI tract and translocation to the sys-temic organs after oral administration. J Pharm 105:157–168

Johnston CJ, Finkelstein JN, Mercer P, Corson N, Gelein R, Oberdörster G (2000) Pulmonary effects induced by ultrafine PTFE particles. Toxicol Appl Pharmacol 168:208–215

Khandoga A, Stampfl A, Takenaka S, Schulz H, Radykewicz R, Kreyling W, Krombach F (2004) Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circu-lation 109:1320–1325

Koch AM, Reynolds FM, Merkle HP, Weissleder R, Josephson L (2005) Transport of surface-modi-fied nanoparticles through cell monolayers. Chembiochem 6:337–345

Kotter JM, Zieger G (1992) Sarkoidale Granu-lomatose nach mehrjähriger Zirkoniumexpositi-on, eine Zirkoniumlunge. Pathologe 13:104–109

Krämer U, Ranft U, Seitner-Sorge G, Behrendt H, Ring J (2003) Einfluss von Luftverunreinigun-gen auf die Atemwegsgesundheit von Kindern. Umwelt-Medizin-Gesellschaft 16:245–249

Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A (2002) Translocation of ultrafine insoluble iridium particles from lung epithelium to extra-pulmonary organs is size dependent but very low. J Toxicol Environ Health 65:1513–1530

Kreyling WG (2002) Deposition, Retention und Clearance von ultrafeinen Partikeln. BIA-Work-shop „Ultrafeine Aerosole an Arbeitsplätzen“, Sankt Augustin

Krug HF (2005) Wirkung von synthetischen Nanopartikeln in Arbeits- und Umweltbereichen. unter http://dialog-nanopartikel.de

Lam CW, James JT, McCluskey R, Hunter RL (2004) Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intra-tracheal instillation. Toxicol Sci 77:126–134

Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL (2006): A review of carbon nano-tube toxicity and assessment of potential occupa-tional and environmental health risks. Crit Rev Toxicol 36:189–217

Lehn JM (2002) Toward self-organization and complex matter. Science 295:2400–2403

Lomer MC, Thompson RP, Powell JJ (2002) Fine and ultrafine particles of the diet: influence on the mucosal immune response and associa-tion with Crohn’s disease. Proc Nutr Soc 61:123–130

Luther W (Hrsg. 2004) Industrial application of nanomaterials–chances and risks. unter http://www.nanotruck.de/pdf/industrial_appli cations_of_nanomaterials.pdf

Möhlmann C (2005) Exposition gegenüber ultrafeinen Partikeln an Arbeitsplätzen. unter http://dialog-nanopartikel.de/09%20Moehl mann.pdf

Monteiro-Riviere NA, Nemanich RJ, Inman AO, Wang YY, Riviere JE (2005) Multi-walled carbon nanotube interactions with human epi-dermal keratinocytes. Toxicol Lett 155:377–384

Müller M, Buchter A (2007) Nanopartikel in der Arbeitsmedizin: Wo stehen wir? Wo wollen wir hin?. In: NanoBioNet (Hrsg.) Sicherheit der Nanotechnologie.

Nefzger M, Kreuter J, Voges R, Liehl E, Czok R (1984) Distribution and elimination of poly-methyl methacrylat nanoparticles after peroral administration to rats. J Pharm Sci 73:1309–1311

Nemmar A, Delaunois A, Nemery B, Dessy-Doizé C, Beckers JF, Sulon J, Gustin P (1999) Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fibers and mast cells. Toxicol Appl Phramacol 160:250–261

Nemmar A, Vanbilloen H, Hoylaerts MF, Hoet PH, Verbruggen A, Nemery B (2001) Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med 164:1665–1668

Nemmar A (2002) Passage of inhaled particles into the blood circulation in humans. Circula-tion 105:411–414

Nemmar A, Hoylaerts MF, Hoet PH, Nemery B (2004) Possible mechanisms of the cardio-vascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol lett 149:243–253

Nigavekar SS, Sung LY, Ilanes M, El Jawahri A, Lawrence TS, Becker CW, Balogh L, Kahn MK (2004) 3H dendrimer nanoparticle organ/tumor distribution. Pharm Res 21:476–483

Oberdörster G, Ferin J, Soderholm S, Gelein R, Baggs R, Morrow PE (1999) Increased pulmo-nary toxicity of inhaled ultrafine particles: due to overload alone? Inhal Toxicol 38:295–302

Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, Kreyling W, Cox C (2002) Extrapulmonary translocation of ultrafine car-bon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health 65: 1531–1543

Oberdörster G (2002) Verteilung ultrafeiner Aerosole im Organismus. BIA-Workshop „Ultra-feineAerosole anArbeitsplätzen“, SanktAugustin

Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C (2004) Trans-location of inhaled ultrafine particles to the brain. Inhal Toxicol 16. 437–445

Oberdörster G (2005) Biokinetik von Nano-partikeln: Grund zur Besorgnis? Vortrag am 11. Oktober 2005 im BUM Bonn unter http://dialog-nanopartikel.de05%20Oberdoerster.pdf

Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives 7:823–839

Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J (1997) Respiratory effects are asso-ciated with the number of ultrafine particles. Am J Respir Crit Care Med 155:1376–1383

Peters A, Dockery DW, Muller JE, Mittleman MA (2001) Increased particulate air pollution and the triggering of myocardial infarction. Circu-lation 103:2810–2815

Pope CA III, Dockery DW (1999) Epidemio-logy of particle effects. In: ei]Holgate ST, Samet JM, Koren HS, Maynard RL (Hrsg.) Air pollution and health. San Diego, Academic Press

Pott F, Roller M (2003) Untersuchung zur Kan-zerogenität granulärer Stäube an Ratten. unter www.baua.de/fors/f1843htm

Riediger G, Möhlmann C (2003) Ultrafeine Aerosole an Arbeitsplätzen. Gefahrstoffe–Reinhalt Luft 61:429–434

Salvi S, Blomberg A, Rudell B, Kelly F, Sandstrom T, Holgate ST, Frew A (1999) Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med 159:702–709

Samet JM, Dominici F, Cuuriero FC, Coursac I, Zeger SL (2000) Fine particulate air pollution and mortality in 20 US cities. N Eng J Med 343:1742–1749

Sayes CM, Fortner JD, Guo W, Lyon D, Colvin VL (2004) The differential cytotoxicity of water-soluble fullerens. Nano Letters 4:1881–1887

Schneider J, Freitag F, Rödelsperger K (1994) Durch Zirkonium-Einwirkung am Arbeitsplatz verursachte exogen-allergische Alveolitis. Ar-beitsmed Sozialmed Umweltmed 29:382–385

Schürch S, Gehr P, Im Hof V, Geiser M, Green F (1990) Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Phy-siol 80:17–32

Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG (2004) Long-term clearance kinetics of inhaled ultrafine in-soluble iridium particles from the rat lung, in-cluding transient translocation into secondary organs. Inhal Toxicol 16:453–459

Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF (2002) Particulate air pollution indices progression of atherosclero-sis. J M Coll Cardiol 39:935–942

Volkheimer G (1974) Passage of particles through the wall of the gastrointestinal tract. Environ Health Perspect 9:215–225

von Klot S, Wolke G, Tuch T, Heinrich J, Dockery DW, Schwartz J, Kreyling WG, Wichmann HE, Peters A (2002) Increased asthma medication use in association with ambient fine und ultra-fine particles. Eur Respir J 20:691–702

Westedt U, Barbu-Tudoran L, Schaper AK, Kalinowski M, Alfke H, Kissel T (2002) De-position of nanoparticles in the aterial vessel by porous balloon catheters: localization by con-focal laser scanning microscopy and trans-mission electron microscopy. AAPS Pharm Sci 4:E41

Wichman HE (2002) Epidemiologie ultrafeiner Partikel, BIA-Workshop „Ultrafeine Aerosole an Arbeitsplätzen“, Sankt Augustin

Wikipedia (Hrsg. 2007): Nanotechnologie. unter http://de.wikipedia.org/wiki/Nanotechnologie